News
For pharma comapnies, combo drugs turn cash cow
www.dnaindia.com
[Daily News & Analysis] - “Work is going on and we will take it to emerging countries and markets in Africa,” said Arun Sawhney, CEO and MD of Ranbaxy, in a recent conference call, referring to the malaria combo drug. However, though they reduce dosages for patients, combo
Lipitor clone gets Ranbaxy $600 million
www.dnaindia.com
[Daily News & Analysis] million has been raked in, a testimony to Ranbaxy's successful monetisation of the exclusivity opportunity. Ranbaxy's CEO and MD Arun Sawhney told analysts in a conference call that the company enjoyed a 55% market share during the exclusivity period.
Ranbaxy reports significant sales growth in Q
www.zenopa.com
[Zenopa] - Arun Sawhney, chief executive officer and managing director at Ranbaxy, said: "Sales and profitability grew in the quarter with overall improvement across major regions, aided further by exclusivity sales in some of the key markets." Earlier this month
Google News: 印度：中国商品充斥印度市场印方深感忧虑(图)
[汉丰网] - 印度制药公司Ranbaxy Laboratories Ltd.董事总经理Arun Sawhney表示，对外界而言中国看似非常具有吸引力，是个巨大的市场，但国外仿制药生产商却一直没能弄清楚如何才能在中国市场获得成功。在发布了约40种产品但均
sorted by relevance / date